Monthly Archives - April 2020

Corbus Announces Publication of Lenabasum Systemic Sclerosis Double-Blind, Placebo-Control Phase 2 Clinical Trial Results in Arthritis & Rheumatology

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system (ECS), today announced the publication of results from the double-blind, randomized, placebo-controlled Phase 2 trial assessing the safety and efficacy of lenabasum in 42 patients with diffuse cutaneous systemic sclerosis in Arthritis & Rheumatology. Read more >>

COVID-19 Response Fund supports innovation solutions during pandemic

The Dartmouth General Hospital Foundation is raising money for a COVID-19 Response Fund to support the needs of staff and patients during the pandemic. According to Dr. Kevin Spencer, an emergency department physician at the Dartmouth General Hospital and mechanical engineer, the COVID-19 Response Fund is focused on three specific areas…His team has joined forces with Spring Loaded Technology, an organization that develops and manufactures novel assistive devices that reduce pain and restore mobility, to produce face shields. Read […]